Which hedge funds own IRMD? IRADIMED CORP, Q2 2026 13F holders
22 tracked hedge funds disclosed a position in IRMD (IRADIMED CORP) in their Q2 2026 13F filings, worth $130.7m in total. The largest holder by portfolio weight is Nine Ten Capital Management LLC at 7.6% of its book. 3 opened a new position this quarter: Entropy Technologies, LP, Magnetar Financial LLC, Marshall Wace, LLP. 6 exited: Boothbay Fund Management, LLC, ExodusPoint Capital Management, LP, Polen Capital.
- 22
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 3
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 6
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $3.0m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $12.9m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $131m
- Combined value Sum of the holders' reported positions in the security.
- 1.8%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Boothbay Fund Management, LLC | 0.02% | $655k |
| ExodusPoint Capital Management, LP | 0.01% | $1.5m |
| Polen Capital | 0.01% | $2.0m |
| Millennium Management LLC | 0.0% | $3.9m |
| Citadel Advisors LLC | 0.0% | $3.1m |
| D. E. Shaw & Co., Inc. | 0.0% | $1.7m |
Ownership over time
Who discovered IRMD first? Beta
The run: Q3 2017 → Q3 2018, +287%
| Nine Ten Capital Management LLC high conviction | Q2 2023 | – | +15.3 pts |
| Roubaix Capital, LLC | Q3 2019 | – | +0.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.